HistoIndex and Houston Research Institute Join Forces to Enhance MASH Diagnostics HistoIndex has formed a strategic alliance with Houston Research Institute to enhance diagnostic services for patients with MASH, leveraging AI technology.

HistoIndex and Houston Research Institute Join Forces to Enhance MASH Diagnostics #USA #Houston #MASH #HistoIndex #AI_Pathology

HistoIndex Unveils FibroSIGHT™ Plus at Liver Meeting 2025 Showcasing Advances in Diagnostics At AASLD's Liver Meeting 2025, HistoIndex introduces FibroSIGHT™ Plus, enhancing diagnostics for liver diseases and exhibiting groundbreaking research.

HistoIndex Unveils FibroSIGHT™ Plus at Liver Meeting 2025 Showcasing Advances in Diagnostics #United_States #Washington_D.C. #HistoIndex #Digital_Pathology #FibroSIGHT

HistoIndex's FibroSIGHT™ Plus: A Major Leap in Fibrosis Diagnosis Through AI Technology HistoIndex has launched FibroSIGHT™ Plus, an innovative tool that employs AI for quantitative fibrosis assessment, transforming diagnostic processes in liver disease.

HistoIndex's FibroSIGHT™ Plus: A Major Leap in Fibrosis Diagnosis Through AI Technology #Singapore #HistoIndex #FibroSIGHT_Plus #qFibrosis

HistoIndex Receives SGD9 Million Funding to Fuel Expansion and Innovation in Digital Pathology HistoIndex's recent SGD9 million investment will enhance its digital pathology solutions, driving advances in liver disease diagnostics and treatment options.

HistoIndex Receives SGD9 Million Funding to Fuel Expansion and Innovation in Digital Pathology #Singapore #AI_Technology #HistoIndex #Digital_Pathology

HistoIndex Introduces FibroSIGHT™: A Groundbreaking Tool for MASH Patient Care HistoIndex has launched FibroSIGHT™, a pioneering digital pathology solution for the assessment of liver fibrosis in MASH patients, enhancing clinical care globally.

HistoIndex Introduces FibroSIGHT™: A Groundbreaking Tool for MASH Patient Care #USA #Irvine #MASH #HistoIndex #FibroSIGHT

Revolutionizing Liver Disease Evaluation: AI in Pathology Enhances Accuracy A groundbreaking study highlights how AI technology is improving liver fibrosis evaluations, making pathology more reliable and efficient.

Revolutionizing Liver Disease Evaluation: AI in Pathology Enhances Accuracy #Singapore #MASH #HistoIndex #AI_Digital_Pathology